Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H02451 | Congenital disorder of glycosylation with defective fucosylation | ... (CDGF) is a rare inherited metabolic disorder due to abnormalities in fucosylation, which is an enzymatic process of incorporating L-fucose into the N- and O-glycans of proteins or glycolipids. Fucosylation ... | Inherited metabolic disorder |
(CDGF1) FUT8 [HSA:2530] [KO:K00717] (CDGF2) FCSK [HSA:197258] [KO:K05305] |
|
H02469 | Cone-rod synaptic disorder | ... and a normal fundus appearance. Recently, It has been reported that mutations in RIMS2 cause a syndromic congenital cone-rod synaptic disease (CRSDS) with neurodevelopmental and pancreatic involvement. | Nervous system disease |
(CRSD) CABP4 [HSA:57010] [KO:K23531] (CRSDS) RIMS2 [HSA:9699] [KO:K15297] |
|
H02488 | Cardiac-urogenital syndrome | Cardiac-urogenital syndrome (CUGS) is characterized by congenital diaphragmatic hernia, congenital heart disease and genitourinary abnormalities. Mutations in MYRF have been identified in patients. MYRF ... | Congenital malformation | MYRF [HSA:745] [KO:K24768] | |
H02516 | Alcoholic liver disease | ... caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated ... | Digestive system disease | hsa04936 Alcoholic liver disease | |
H02520 | Phosphoenolpyruvate carboxykinase deficiency | ... carboxykinase deficiency (PCKD) is a rare disorder of gluconeogenesis presenting with recurrent hypoglycemia, hepatic dysfunction, and lactic acidosis. There are two discrete subcellular isoforms of phosphoenolpyruvate ... | Inherited metabolic disorder |
(PCKDC) PCK1 [HSA:5105] [KO:K01596] (PCKDM) PCK2 [HSA:5106] [KO:K01596] |
|
H02609 | Craniodiaphyseal dysplasia | ... autosomal dominant sclerotic bone disorder characterized by distinctive facial dysmorphism-prominent zygomatic bones, broadening of the center of the face, hypertelorism, a small upturned tip of the nose, prominent ... | Musculoskeletal disease | SOST [HSA:50964] [KO:K16834] | |
H02619 | Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome | ... (HADDTS) is caused by a pathogenic CTBP1 missense mutation. CTBP1 is the transcriptional corepressor. The enzymatic constituents of the CTBP1 corepressor complex mediate coordinated histone modifications. | Congenital malformation | CTBP1 [HSA:1487] [KO:K04496] | |
H02631 | Melorheostosis | ... asymmetric bone overgrowth and functional impairment. Recent studies indicate that most cases arise from somatic MAP2K1 mutations although a small number may arise from other genes in related pathways. | Musculoskeletal disease | MAP2K1 [HSA:5604] [KO:K04368] | |
H02647 | Macrodactyly | ... consisting of enlargement of all tissues localized to the terminal portions of a limb. Macrodactyly is attributed to a somatic mutation in PIK3CA, a component of the mTOR pathway-related overgrowth disorders. | Congenital malformation | PIK3CA [HSA:5290] [KO:K00922] | |
H02722 | Nevus comedonicus | ... noninflammatory background and following the lines of Blaschko. The cause of NC has been proven to be somatic mutations of the NEK9 gene. NEK9 is a serine/threonine kinase that functions as an important regulator ... | Congenital malformation | NEK9 [HSA:91754] [KO:K20878] | |
H02731 | Transient infantile hypertriglyceridemia | ... and NAD+. The hypertriglyceridemia is associated with hepatomegaly and moderately elevated transaminases that may decrease later in life, persistent fatty liver, and the development of hepatic fibrosis. | Inherited metabolic disorder | GPD1 [HSA:2819] [KO:K00006] | |
H02751 | Orthostatic hypotension | Orthostatic hypotension (ORTHYP) is caused by an excessive fall of cardiac output or by defective or inadequate vasoconstrictor mechanisms. Characteristic symptoms include lightheadedness, dizziness, and ... | Cardiovascular disease |
(ORTHYP1) DBH [HSA:1621] [KO:K00503] (ORTHYP2) CYB561 [HSA:1534] [KO:K08360] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |